Found 9 matching trials
Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer NA This study aims to observe and explore the efficacy and safety of Anlotinib...
Show More Learn More & Join Trial
Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma PHASE2 There is currently no standard first-line treatment for stage PPGL, and the...
Show More Location
Cancer Center, Sun Yat-sen University
Learn More & Join Trial
Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma. PHASE2 This is a prospective, open-label single-arm, exploratory, two-stage design...
Show More Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Learn More & Join Trial
Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC) PHASE2 This study will explore the effectiveness and safety of the combination the...
Show More Location
Multiple Locations
Learn More & Join Trial
Metastatic Nasopharyngeal Carcinoma PHASE1 To evaluaate the efficacy and safety of the regimen incuding Penpulimab, Ge...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. PHASE1 This is a Phase Ib clinical study to evaluate the efficacy and safety of TQ...
Show More Location
Fuyang Cancer Hospital
Learn More & Join Trial
A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). PHASE1 This is an open, single-arm, multi-center clinical study designed to evalua...
Show More Location
Gansu Wuwei Cancer Hospital
Learn More & Join Trial
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma PHASE2 This is an open label, randomized, phase Ⅱ, multi-cohort study to treat sub...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGC NA * 1\. Main objective: to evaluate the pathological complete response (pCR) ...
Show More Location
The First Affiliated Hospital of Air Force Military Medical University
Learn More & Join Trial